Breviscapine suppresses the growth of non-small cell lung cancer by enhancing microRNA-7 expression

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Biosciences

• Publication date

  2017-02-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12038-017-9670-0PMID 28229971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas

  2016cited by this paper
• MicroRNA-7 enhances cytotoxicity induced by gefitinib in non-small cell lung cancer via inhibiting the EGFR and IGF1R signalling pathways

  2015cited by this paper
• Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients

  2015cited by this paper
• Vitexin protects brain against ischemia/reperfusion injury via modulating mitogen-activated protein kinase and apoptosis signaling in mice.

  2015cited by this paper
• MicroRNA-7 inhibits the malignant phenotypes of non‑small cell lung cancer in vitro by targeting Pax6.

  2015cited by this paper
• miR‐7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1

  2015cited by this paper
• Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.

  2015cited by this paper
• Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium

  2015cited by this paper
• Docetaxel inhibits the proliferation of non-small-cell lung cancer cells via upregulation of microRNA-7 expression.

  2015cited by this paper
• Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.

  2015cited by this paper
• miR-7 expression in serous ovarian carcinomas.

  2015cited by this paper
• Serum miR-21 level: a potential diagnostic and prognostic biomarker for non-small cell lung cancer.

  2015cited by this paper
• Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells.

  2014cited by this paper
• Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma

  2014cited by this paper
• Radiation induces acid tolerance of Clostridium tyrobutyricum and enhances bioproduction of butyric acid through a metabolic switch

  2014cited by this paper
• MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer

  2014cited by this paper
• MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1

  2014cited by this paper
• miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.

  2014cited by this paper
• Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18

  2013cited by this paper
• PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer

  2013cited by this paper
• Improving Outcomes in Advanced Lung Cancer: Maintenance therapy in non-small-cell lung carcinoma.

  2013cited by this paper
• Downregulation of miR‐7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells

  2013cited by this paper
• Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer.

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Metabolic transformation of DMBA-induced carcinogenesis and inhibitory effect of salvianolic acid b and breviscapine treatment.

  2012cited by this paper
• Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review

  2011cited by this paper
• Inhibitory effects on bacterial growth and b‐ketoacyl‐ACP reductase by different species of maple leaf extracts and tannic acid

  2010cited by this paper
• Breviscapine‐induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity

  2010cited by this paper
• Breviscapine, a traditional Chinese medicine, alleviates myocardial ischaemia reperfusion injury in diabetic rats

  2008cited by this paper
• MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.

  2008cited by this paper
• Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.

  2008cited by this paper
• Neuroprotective effects of breviscapine against apoptosis induced by transient focal cerebral ischaemia in rats

  2008cited by this paper
• Renoprotective Effect of Breviscapine through Suppression of Renal Macrophage Recruitment in Streptozotocin-Induced Diabetic Rats

  2006cited by this paper
• A Study of the Cardioprotective Effect of Breviscapine During Hypoxia of Cardiomyocytes in vitro and During Myocardial Infarction in vivo

  2004cited by this paper
• MicroRNAs and cancer.

  2003cited by this paper
• Role or Survival?

  1972cited by this paper

• Zinc finger protein 184 prevents α-synuclein preformed fibril-mediated neurodegeneration through the interleukin enhancer binding factor 3-microRNA-7 pathway

  2025cites this paper
• Breviscapine reverses doxorubicin resistance in breast cancer and its related mechanisms

  2023cites this paper
• Breviscapine regulates the proliferation, migration, invasion, and apoptosis of colorectal cancer cells via the PI3K/AKT pathway

  2023cites this paper
• Scutellarin prevents acute alcohol-induced liver injury via inhibiting oxidative stress by regulating the Nrf2/HO-1 pathway and inhibiting inflammation by regulating the AKT, p38 MAPK/NF-κB pathways

  2023cites this paper
• miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients

  2023cites this paper
• Polyphenols as Lung Cancer Chemopreventive Agents by Targeting microRNAs

  2022cites this paper
• Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology

  2022cites this paper
• Breviscapine Participates in the Progression of Prostate Cancer by Inhibiting ZFP91 Expression through Upregulation of MicroRNA-129-5p

  2021cites this paper
• How metformin affects various malignancies by means of microRNAs: a brief review

  2021cites this paper
• Anticancer mechanism of breviscapine in non-small cell lung cancer A549 cells acts via ROS-mediated upregulation of IGFBP4

  2021cites this paper
• Flavonoid compound breviscapine suppresses human osteosarcoma Saos‐2 progression property and induces apoptosis by regulating mitochondria‐dependent pathway

  2020cites this paper
• Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway.

  2020cites this paper
• MicroRNAs as Therapeutic Targets for Anticancer Drugs in Lung Cancer Therapy.

  2020cites this paper
• Development of a gold nanoparticle-based lateral-flow strip for the detection of dinitolmide in chicken tissue.

  2020cites this paper
• Breviscapine provides a neuroprotective effect after traumatic brain injury by modulating the Nrf2 signaling pathway

  2019cites this paper
• Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients.

  2019cites this paper
• Role of scutellarin in human cancer—A review

  2019cites this paper
• Breviscapine ameliorates CCl4-induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation

  2018cites this paper
• Vicenin‐2 acts as a radiosensitizer of the non‐small cell lung cancer by lowering Akt expression

  2018cites this paper
• MiR-185 inhibits tumor growth and enhances chemo-resistance via targeting SRY-related high mobility group box transcription factor 13 in non-small-cell carcinoma.

  2018cites this paper
• Clinical benefits and pharmacology of scutellarin: A comprehensive review

  2018cites this paper
• Breviscapine (BVP) inhibits prostate cancer progression through damaging DNA by minichromosome maintenance protein-7 (MCM-7) modulation.

  2017cites this paper